RTI signs exclusive distribution deal with Zimmer
RTI Biologics has signed an exclusive, 10-year distribution agreement with Zimmer Dental whereby Zimmer will market and distribute RTI implants for the dental market worldwide.
RTI Biologics has signed an exclusive, 10-year distribution agreement with Zimmer Dental whereby Zimmer will market and distribute RTI implants for the dental market worldwide.
Dentists and hygienists in Montana are divided over who should be responsible for placing dental sealants in schoolchildren if a proposed bill passes, according to
IPS Empress Direct offers the aesthetics of a ceramic combined with the convenience of a composite – due to a wide range of shades, various
Komet USA now offers DF Cutters, tungsten carbide instruments designed for creating a defined roughness of precious and nonprecious metal surfaces to be used in
Tooth whitening was among the ‘back-to-school’ essentials for teenagers, their parents have revealed. About 45% of parents responding to a poll say that hair highlights,
Air Techniques has added a patented antimicrobial coating to its line of AirStar dental compressors to inhibit the growth and transmission of harmful bacteria, the
Early complications following lip and tongue piercings are frequent and might be minimized with proper overall oral healthcare, according to a study in Quintessence International
Plaque-causing bacteria can escape from the mouth into the bloodstream and increase the risk of heart attack, according to research from the University of Bristol.
The use of MI Paste Plus (GC America) with Recaldent — containing casein phosphopeptide-amorphous calcium phosphate and fluoride (CPP-ACPF) — helps prevent decalcification in orthodontic
The British Dental Practice Managers’ Association will have the theme, We’re in tune with youat stand H07 at the BDTA Dental Showcase, 14-16 October, ExCeL,
The oral care probiotic EvoraPlus will soon become available at GNC stores across the U.S., according to Oragenics, the company that makes EvoraPlus. GNC has
Accused of aggressively marketing Botox to medical professionals to encourage off-label use, pharmaceutical giant Allergan will pay $600 million to settle civil and criminal accusations